Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age

被引：63
作者：
Mercier, Toine [1 ,2 ]
Guldentops, Ellen [2 ]
Lagrou, Katrien [1 ,3 ,4 ]
Maertens, Johan [1 ,2 ]
机构：
[1] Katholieke Univ Leuven, Lab Clin Bacteriol & Mycol, Dept Microbiol & Immunol, Leuven, Belgium
[2] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium
[4] Univ Hosp Leuven, Natl Reference Ctr Mycosis, Leuven, Belgium
来源：
FRONTIERS IN MICROBIOLOGY | 2018年 / 9卷
关键词：
galactomannan; kinetics; invasive aspergillosis; prognosis; outcome; CELL TRANSPLANT RECIPIENTS; MYCOSES STUDY-GROUP; PULMONARY ASPERGILLOSIS; SERUM GALACTOMANNAN; NEUTROPENIC PATIENTS; ENZYME-IMMUNOASSAY; ANTIFUNGAL THERAPY; CIRCULATING GALACTOMANNAN; EUROPEAN-ORGANIZATION; CASPOFUNGIN THERAPY;
D O I：
10.3389/fmicb.2018.00661
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Detection of galactomannan has become widely available for diagnosing invasive aspergillosis. The test characteristics, using the Platelia (TM) enzyme-immunoassay, have been well described. This assay could potentially also be useful for the early evaluation of the efficacy of antifungal therapy and for predicting the outcome in terms of response and survival. In this systematic review, we assessed the available evidence for the use of serum galactomannan at baseline as a prognostic marker, and the predictive value of serum galactomannan kinetics after initiation of antifungal therapy. Overall, serum galactomannan at baseline and galactomannan kinetics appear to be good predictors of therapy response and survival. However, breakpoints for predicting therapy failure and validation in different patient populations are still lacking.
引用
收藏
页数：10
相关论文
共 63 条
  • [1] Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with β-lactam antibiotics in patients with hematological disorders
    Aubry, A
    Porcher, R
    Bottero, J
    Touratier, S
    Leblanc, T
    Brethon, B
    Rousselot, P
    Raffoux, E
    Menotti, J
    Derouin, F
    Ribaud, P
    Sulahian, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) : 389 - 394
  • [2] RECEPTOR-MEDIATED CLEARANCE OF ASPERGILLUS GALACTOMANNAN
    BENNETT, JE
    FRIEDMAN, MM
    DUPONT, B
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05) : 1005 - 1010
  • [3] Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients
    Bergeron, Anne
    Porcher, Raphael
    Menotti, Jean
    Poirot, Jean Louis
    Chagnon, Karine
    Vekhoff, Anne
    Cornet, Muriel
    Isnard, Francoise
    Raffoux, Emmanuel
    Brethon, Benoit
    Lacroix, Claire
    Touratier, Sophie
    Latge, Jean Paul
    Bouges-Michel, Claire
    Tazi, Abdellatif
    Derouin, Francis
    Ribaud, Patricia
    Sulahian, Annie
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (03) : 823 - 830
  • [4] Invasive aspergillosis in allogeneic stem cell transplant recipients: Increasing antigenemia is associated with progressive disease
    Boutboul, F
    Alberti, C
    Leblanc, T
    Sulahian, A
    Gluckman, E
    Derouin, F
    Ribaud, P
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) : 939 - 943
  • [5] Hidden Killers: Human Fungal Infections
    Brown, Gordon D.
    Denning, David W.
    Gow, Neil A. R.
    Levitz, Stuart M.
    Netea, Mihai G.
    White, Theodore C.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (165)
  • [6] Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
    Chai, Louis Yi Ann
    Kullberg, Bart Jan
    Earnest, Arul
    Johnson, Elizabeth M.
    Teerenstra, Steven
    Vonk, Alieke G.
    Schlamm, Haran T.
    Herbrecht, Raoul
    Netea, Mihai G.
    Troke, Peter F.
    [J]. PLOS ONE, 2014, 9 (02):
  • [7] Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid
    Chong, G. M.
    Maertens, J. A.
    Lagrou, K.
    Driessen, G. J.
    Cornelissen, J. J.
    Rijnders, B. J. A.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (02) : 428 - 431
  • [8] Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
    De Pauw, Ben
    Walsh, Thomas J.
    Donnelly, J. Peter
    Stevens, David A.
    Edwards, John E.
    Calandra, Thierry
    Pappas, Peter G.
    Maertens, Johan
    Lortholary, Olivier
    Kauffman, Carol A.
    Denning, David W.
    Patterson, Thomas F.
    Maschmeyer, Georg
    Bille, Jacques
    Dismukes, William E.
    Herbrecht, Raoul
    Hope, William W.
    Kibbler, Christopher C.
    Kullberg, Bart Jan
    Marr, Kieren A.
    Munoz, Patricia
    Odds, Frank C.
    Perfect, John R.
    Restrepo, Angela
    Ruhnke, Markus
    Segal, Brahm H.
    Sobel, Jack D.
    Sorrell, Tania C.
    Viscoli, Claudio
    Wingard, John R.
    Zaoutis, Theoklis
    Bennett, John E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) : 1813 - 1821
  • [9] Discordant rise in galactomannan antigenemia in a patient with resolving aspergillosis, renal failure, and ongoing hemodialysis
    El Saleeby, CM
    Allison, KJ
    Knapp, KM
    Walsh, TJ
    Hayden, RT
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (07) : 3560 - 3563
  • [10] The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis
    Fisher, Cynthia E.
    Stevens, A. Michal
    Leisenring, Wendy
    Pergam, Steven A.
    Boeckh, Michael
    Hohl, Tobias M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (07) : 1001 - 1004
1234567